Pulmonary Complications in Cystic Fibrosis: Past, Present, and Future: Adult Cystic Fibrosis Series
- PMID: 34147501
- PMCID: PMC8727888
- DOI: 10.1016/j.chest.2021.06.017
Pulmonary Complications in Cystic Fibrosis: Past, Present, and Future: Adult Cystic Fibrosis Series
Abstract
1Cystic fibrosis (CF) is an autosomal recessive genetic condition with multisystemic disease manifestations, the most prominent of which occur in the respiratory system. Despite significant developments in disease understanding and therapeutics, each contributing to improved lung function and survival in patients with CF, several pulmonary complications, including pneumothorax, massive hemoptysis, and respiratory failure, continue to occur. In this review, we briefly describe each of these complications and their management and discuss how they impact the care and disease trajectory of individuals in whom they occur. Finally, we discuss the evolving role that palliative care and CF transmembrane conductance regular modulator therapies play in the natural disease course and care of patients with CF.
Keywords: CFTR modulator; complications; cystic fibrosis; hemoptysis; palliative care; pneumothorax; pulmonary hypertension; respiratory failure.
Copyright © 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.
References
-
- Cystic Fibrosis Foundation . Cystic Fibrosis Foundation; 2020. Patient Registry 2019 Annual Data Report.
-
- Rowe S.M., Miller S., Sorscher E.J. Cystic fibrosis. N Engl J Med. 2005;352(19):1992–2001. - PubMed
-
- Flume P.A., Strange C., Ye X., Ebeling M., Hulsey T., Clark L.L. Pneumothorax in cystic fibrosis. Chest. 2005;128(2):720–728. - PubMed
-
- Flume P.A., Yankaskas J.R., Ebeling M., Hulsey T., Clark L.L. Massive hemoptysis in cystic fibrosis. Chest. 2005;128(2):729–738. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
